---
category: news
title: "Dosing of ISM001-055, Oral IPF Therapy, Begins in Phase 1 Trial"
excerpt: "Dosing has begun in healthy volunteers in a Phase 1 clinical trial of ISM001-055, a small molecule potential treatment of idiopathic pulmonary fibrosis (IPF) developed using an artificial intelligence (AI) platform,"
publishedDateTime: 2022-03-07T13:29:00Z
originalUrl: "https://pulmonaryfibrosisnews.com/2022/03/07/dosing-begins-ism001-055-oral-iph-therapy-phase-1-trial/"
webUrl: "https://pulmonaryfibrosisnews.com/2022/03/07/dosing-begins-ism001-055-oral-iph-therapy-phase-1-trial/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: pulmonaryfibrosisnews.com
  domain: pulmonaryfibrosisnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pulmonaryfibrosisnews.com/wp-content/uploads/2022/01/Clinicalmeds.png"
    width: 700
    height: 350
    isCached: true

secured: "Z2YLFpgqz8OwQzJN/Rne7uJKod9lGnqJryC6+Ivr4pmiXB4xkNuJsVhBvIOGscS/IQMrwx1ghRI7CsxhhMN3GBb8mFKXEN4b/LfK3hw2zkEF/UbI3LjSJgOZvQ1TV2t4C+ip67kZFz+om8OPGFH9S57IAe8AnhQN+dkZiKxHllwzoiX2J+A4gphrfBeJSUlIPBG5UclB/98l03KumT4GJmDpx4Bde/BUuw5z1u3upOOTF0Lt9nwulGUYCHPdF7JZIg3YCfNtn7aFQ0+VGdwDQdvw2NBCD8YUS67+ktjk3vqkXhQDP8D2OUTbNSYJDqPh4IDw0xlm5SxEeogdX049zuPAQn5tBhWgDLq2Np3D5j4=;uAFw2GTwrw1IAPklTKkRww=="
---

